Related Experiment Video
Updated: Aug 8, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
[Kinetics of C-reactive protein release in different forms of acute coronary syndrome]
Pedro L Sánchez1, María V Rodríguez, Eduardo Villacorta
1Instituto de Ciencias del Corazón (ICICOR), Hospital Clínico Universitario de Valladolid, Ramón y Cajal 3, 47005 Valladolid, Spain. pedrolsanchez@secardiologia.es
Insights
C-reactive protein (CRP) levels vary significantly in acute coronary syndromes, with peak levels correlating with myocardial damage. Understanding CRP kinetics is crucial for biomarker application in heart attack patients.
Area of Science:
- Cardiology
- Biomarker research
- Inflammation markers
Context:
- Acute coronary syndromes (ACS) require precise diagnostic tools.
- C-reactive protein (CRP) is an inflammatory marker with potential clinical utility.
- Understanding CRP kinetics in ACS can refine its application.
Purpose:
- To investigate the kinetics of C-reactive protein (CRP) in patients with different types of acute coronary syndrome (ACS).
- To determine the relationship between CRP levels and the extent of myocardial damage.
- To assess the potential of CRP as a prognostic or diagnostic biomarker in ACS.
Summary:
- CRP levels increase post-admission in ACS patients.
- Peak CRP levels differ significantly across ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina.
- Maximum CRP levels correlate with the degree of myocardial necrosis, although admission CRP levels are similar across groups.
Impact:
- The distinct CRP release patterns in ACS subtypes necessitate consideration in study design.
- CRP kinetics may offer insights into the severity and progression of myocardial injury.
- This research highlights the importance of temporal CRP measurements for accurate interpretation in ACS.
Introduction And Objectives:
Better knowledge of C-reactive protein (CRP) kinetics could lead to improved clinical application of this biomarker.
Methods:
We studied 110 patients: 42 had ST-elevation acute myocardial infarction (STEMI), 35 had non-ST-elevation acute myocardial infarction (NSTEMI), and 33 had unstable angina. Patients were admitted to our institution within 6 hours of symptom onset. The levels of CRP, troponin-I, and creatine kinase MB fraction (CK-MB) were measured on admission and every 6 hours during the first 48 h. The CRP level was also measured daily until hospital discharge.
Results:
The median (interquartile range) CRP level increased relative to baseline from 6 hours after admission, from 5 (2-9) mg/L to 6 (3-10) mg/L (P=.004). Although, CRP levels on admission were similar in all groups, there was a significant difference in peak CRP level: it was 67 (36-112) mg/L in the STEMI group, 29 (20-87) mg/L in the NSTEMI group, and 18 (12-36) mg/L in the unstable angina group. The maximum CRP level was observed 49 (38-53) hours after the onset of symptoms, but occurred later in patients with STEMI. Although there was only a weak non-significant correlation between CRP and troponin levels (r=0.135) at admission, the maximum CRP level was found to be influenced by the degree of myocardial damage (r=0.496; P< .001).
Conclusions:
The pattern of CRP release observed was clearly different in different forms of acute coronary syndrome. Although the CRP level measured at admission was similar in all patient groups, it was influenced by the degree of early myocardial tissue necrosis. This variation in CRP kinetics should be taken into consideration when designing future studies.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care
